European Journal of Cardiovascular Medicine

Hypertension — defined clinically as a systolic blood pressure (SBP) ≥140 mmHg and/or diastolic blood pressure (DBP) ≥90 mmHg on repeated measurement — is the most prevalent modifiable risk factor for cardiovascular disease (CVD), stroke, myocardial infarction, heart failure, and chronic kidney disease (CKD) worldwide [1]. The World Health Organization estimates that approximately 1.28 billion adults aged 30–79 years are living with hypertension globally, and fewer than one in five have their blood pressure adequately controlled [2].

High systolic blood pressure was ranked the single leading risk factor for attributable mortality in the Global Burden of Disease 2019 study, responsible for approximately 19.2% of all deaths globally [3]. The epidemiological burden has been shifting markedly towards low- and middle-income countries (LMICs), where rapid urbanization, nutritional transition, and inadequate primary healthcare infrastructure converge to accelerate incidence while limiting detection and management [4].

A central and evolving question in global cardiovascular epidemiology concerns whether hypertension prevalence is higher in urban or rural populations — and how this relationship is changing. Urban environments have historically been associated with higher hypertension risk through dietary transitions, sedentary occupations, obesity, alcohol use, and psychosocial stress [5]. However, rural populations face a distinctly different risk profile: limited healthcare access, low health literacy, high salt diets, aging demographics, and rising rates of overweight create conditions for silent, undiagnosed, and uncontrolled hypertension [6].

Understanding the differential burden and risk factor landscape across urban and rural settings is essential for the design of cost-effective, context-specific public health interventions. This paper synthesizes the current global evidence on hypertension prevalence, risk factors, and the awareness-treatment-control cascade in urban versus rural populations, drawing on large-scale meta-analyses, multi-country studies, and regional data, with particular attention to LMICs where the epidemiological transition is most pronounced.

This review synthesizes evidence from peer-reviewed sources identified through PubMed, Web of Science, and Google Scholar. Studies were included if they: (1) reported hypertension prevalence in both urban and rural adult populations; (2) used measured blood pressure (at least two readings with a standardised device) as the primary diagnostic criterion; (3) were population-based with valid probability sampling; and (4) were published in English between January 2010 and March 2018. Hypertension was defined as SBP ≥140 mmHg and/or DBP ≥90 mmHg, and/or self-reported use of antihypertensive medication — consistent with JNC-7 and 2018 ESC/ESH guidelines. Studies using exclusively self-reported diagnosis without BP measurement were excluded. Data extraction focused on: (a) crude and age-standardized prevalence estimates by urban-rural setting; (b) prevalence of key modifiable risk factors; and (c) rates of hypertension awareness, pharmacological treatment, and blood pressure control. Uncertainty is reported as 95% confidence intervals where available

3.1  Global Prevalence: Urban vs. Rural

The most comprehensive quantitative synthesis is provided by Ranzani et al. [7], a systematic review and meta-analysis of 255 studies reporting 299 surveys from 66 LMICs, covering 19,770,946 participants (mean age 45.4 ± 9 years; 53.0% female; 63.1% from rural areas) between 1990 and 2018. Using random-effects meta-analysis, the study reported:

Urban pooled prevalence: 30.5% (95% CI: 28.9–32.0%)

Rural pooled prevalence: 27.9% (95% CI: 26.3–29.6%)

Urban-rural difference: 2.45% (95% CI: 1.57–3.33%; I²=99.71%; p < 0.001)

While the pooled urban excess is modest in absolute terms, it masks substantial regional heterogeneity. The urban-rural gap was most pronounced in South Asia (7.50%, 95% CI: 5.73–9.26%) and Sub-Saharan Africa (4.24%, 95% CI: 2.62–5.86%). Notably, in Europe and Central Asia — representing more economically advanced LMICs — the gradient reversed, with rural hypertension exceeding urban by 6.04% (95% CI: −9.06 to −3.01%). This reversal aligns with the epidemiological transition model, where rural populations in higher-income settings bear greater cardiovascular risk through aging, economic disadvantage, and healthcare access deficits [8].

A key temporal finding is that between 1990 and 2018, the rate of increase in hypertension prevalence was faster in rural than urban areas. The urban-rural gap decreased significantly with time and inversely correlated with the Human Development Index (HDI) and improvements in infant mortality rate — suggesting that as countries develop, the urban premium in hypertension narrows or reverses [7].

Table 1.  Urban vs. Rural Hypertension Prevalence — Summary of Key Studies

Abbreviations: HIC = high-income country; UMIC = upper-middle-income country; LMIC = lower-middle-income country; LIC = low-income country.

3.2  Regional and Country-Level Patterns

China provides the world's best-documented case of urban-rural hypertension dynamics. Studies consistently show that rural residents have historically had lower prevalence, but the gap is narrowing rapidly, with rural rates growing faster. Regional differences within China are substantial: northern China and large/medium cities show higher prevalence than southern China or smaller cities, likely reflecting dietary sodium patterns and urbanization levels [9]. A meta-analysis of the older Chinese population found an overall prevalence of 47%, with the highest sub-regional rate in Central China (59%) and no significant difference by urban-rural status in the elderly specifically [9].

India presents a complex, heterogeneous landscape. A cross-sectional study in Punjab  [10] — one of the few studies to compare urban and rural Ludhiana simultaneously using JNC-7 and 2017 ACC/AHA dual criteria — found an equal overall prevalence of 62%, yet important asymmetries in the disease cascade: rural residents had significantly fewer diagnosed cases, higher rates of previously unknown hypertension, and greater exposure to low literacy, which was independently associated with poor disease awareness. Hypertension was also more prevalent among males and those with lower educational backgrounds.

In West Africa, urban-rural differences have been mixed across studies, though urbanization is consistently identified as a risk modifier [11]. In East Africa, a 2018 review described how urbanization-related lifestyle changes drive hypertension in cities, while economic stress and healthcare access barriers fuel the rural burden [12]. Both mechanisms ultimately converge on elevated and often unmanaged blood pressure.

3.3  Risk Factors by Setting

Hypertension is a multifactorial condition with both non-modifiable (age, sex, family history, ethnicity) and modifiable risk factors. The distribution of modifiable risk factors differs substantially between urban and rural populations.

Table 2.  Modifiable Hypertension Risk Factors — Urban vs. Rural Populations

BMI = body mass index. Numbers in brackets refer to references in this article.

Urban risk factors operate through a convergent cluster of modern lifestyle determinants. Sedentary occupations, reliance on motorized transport, and reduced physical leisure drive physical inactivity. Urban food environments are dominated by processed, calorie-dense, and sodium-enriched products. The Punjab study [10] identified obesity, sedentary lifestyle, high socioeconomic status, salt intake, stress, alcohol consumption, and hypercholesterolaemia as the principal risk factors in urban cohorts — with high SES paradoxically associated with higher hypertension, reflecting the early-transition pattern in which affluence precedes lifestyle awareness.

Rural risk factors are structurally distinct. Physical distance from health facilities, shortage of trained providers, and absence of blood pressure monitoring equipment mean hypertension frequently goes undetected for years. Low educational attainment limits self-management capacity. Traditional diets — particularly in South Asia and sub-Saharan Africa — are often high in sodium through preserved foods and condiments. Economic insecurity and agricultural debt generate chronic psychosocial stress via neuroendocrine pathways. An increasingly recognized rural risk is the penetration of processed food supply chains into rural markets, driving obesity and sodium intake upward even in previously lower-risk rural communities [7].

3.4  Awareness, Treatment, and Control

The cascade from diagnosis to controlled blood pressure is substantially worse in rural populations across all income settings, representing the most critical gap in rural cardiovascular health.

The PURE study [13], enrolling 142,042 adults across 17 countries in 3 income groupings, found that only 46.5% of hypertensive individuals were aware of their diagnosis overall. Awareness was significantly higher in urban communities compared to rural ones in both LICs (p<0.001) and LMICs (p<0.001). Of those aware, 87.5% were receiving pharmacological treatment, but only 32.5% of those treated achieved blood pressure control. Treatment rates were lowest in LICs (31.7%) and LMICs (36.9%) compared to HICs (46.7%) and UMICs (48.3%).

In Punjab, Singh et al. [10] found that despite equivalent urban-rural prevalence, rural individuals were significantly less likely to know they were hypertensive — with higher numbers of newly detected cases in rural cohorts, signalling a larger reservoir of undiagnosed disease. This finding reinforces that equal prevalence does not imply equal access to the treatment cascade.

In East Africa, Mugisha [12] documented awareness, treatment, and control rates considerably lower in rural communities, with levels of hypertension awareness, treatment, and control substantially below urban comparators and not narrowing at a rate commensurate with the rising rural burden.

Table 3.  Hypertension Awareness–Treatment–Control Cascade by Income Level and Setting (PURE Study, 2013)

HIC = high-income country; UMIC = upper-middle-income country; LMIC = lower-middle-income country; LIC = low-income country. *** p<0.001 for urban vs. rural difference. Source: Chow et al. 2013 [13].

The evidence synthesized in this review supports several important conclusions. First, urban populations have historically shown modestly higher hypertension prevalence in most LMICs, driven by a well-characterized cluster of modern lifestyle risk factors including physical inactivity, dietary sodium excess, obesity, and psychosocial stress. This urban hypertension premium is largest in South Asia and sub-Saharan Africa — regions at earlier stages of the epidemiological transition.

Second, and of greater public health urgency, rural hypertension prevalence is rising faster than urban. The urban-rural gap that characterized the 1990s has substantially narrowed and reversed in more economically advanced settings. This trend is consistent with the broader epidemiological transition: as rural communities adopt processed food supply chains, reduce agricultural labour, and experience aging demographics through youth outmigration, their cardiovascular risk profile converges with — and in some dimensions exceeds — that of urban areas.

Third, the awareness-treatment-control cascade is far worse in rural settings across all income levels. This creates the paradox of potentially equivalent or rising rural prevalence combined with substantially lower detection and management rates — a compounding deficit that translates directly into excess cardiovascular events. Rural populations are thus doubly disadvantaged: rising exposure alongside diminished capacity to respond.

4.1  Mechanisms Driving Urban and Rural Hypertension

The mechanisms driving urban hypertension are relatively well-characterized: dietary transition (increased processed food, sodium, and alcohol; reduced potassium from fresh produce), physical inactivity from occupational and transport changes, excess adiposity, and chronic psychosocial activation through occupational and social stressors [5,12]. These represent the canonical 'diseases of modernization' pathway.

Rural mechanisms are more heterogeneous and context-dependent. In lower-income rural settings, the dominant pathway is systemic: limited healthcare infrastructure prevents detection and treatment, while traditional diets (often sodium-rich), tobacco use, economic stress, and rising obesity create genuine physiological risk. In higher-income rural settings (as seen in Europe and Central Asia), the primary drivers are demographic — older, economically disadvantaged populations with lower access to preventive care and less engagement with health systems [8].

The socioeconomic gradient in hypertension has distinct expressions across income settings. In early-transition LMICs, higher SES (disproportionately urban) predicts higher hypertension — a finding replicated in the Punjab study [10]. In later-transition and high-income settings, the gradient reverses: lower SES predicts higher hypertension, consistent with the pattern seen in developed countries where poverty concentrates dietary risk, stress, and healthcare access barriers [8,14].

4.2  Implications for Intervention

For urban populations, effective interventions require addressing the structural determinants of lifestyle risk at a population level: sodium reformulation and labelling policies, urban planning that promotes walkability and active transport, workplace wellness programs, and mental health services. These are largely policy-level interventions that operate beyond the health sector.

For rural populations, the priority is expanding the reach of the awareness-treatment-control cascade. Community-based screening — using community health workers (CHWs) and mobile health units — has demonstrated efficacy in several LMIC settings for identifying hypertensive individuals who would not present to facilities [6]. Simplified treatment protocols (task-shifted to CHWs), integration of blood pressure measurement into all primary care encounters, subsidized medications, and digitally supported adherence monitoring represent evidence-aligned strategies. Health literacy interventions in local languages can substantially improve self-management capacity [12].

Investment in the rural pharmaceutical supply chain is critical. In many LIC and LMIC rural settings, standard antihypertensives are inconsistently available. Even diagnosed, willing patients face treatment gaps due to supply and affordability barriers. Addressing these structural failures is prerequisite to achieving blood pressure control in rural populations.

4.3  Limitations

This review carries several limitations. The primary studies differ in their definitions of 'urban' and 'rural', limiting strict comparability. Cross-sectional designs dominate the literature, precluding causal inference. Publication bias may favour studies from more accessible geographic areas, potentially under-representing the most under-resourced rural populations. Age standardization is inconsistently applied, complicating demographic-adjusted comparisons. Finally, this review did not conduct a formal new meta-analysis, relying instead on synthesis of existing systematic reviews and primary studies.

Hypertension represents an expanding dual burden across both urban and rural settings, but with distinct profiles and trajectory. Urban populations currently bear a modestly higher prevalence in most LMICs, driven by dietary transition, sedentary behaviour, and psychosocial stress. However, the future of the hypertension epidemic is increasingly rural: prevalence is rising faster in rural areas, the urban excess is narrowing globally, and rural populations suffer substantially greater gaps in awareness, treatment, and control. The most urgent public health priority is not the modest urban-rural gap in prevalence, but the profound gap in the disease management cascade. Bridging this gap requires context-adapted, multi-level interventions: community health worker-based screening, supply-chain investment for affordable antihypertensives, health literacy programs, and integration of hypertension care into primary health systems that genuinely reach rural populations. Policymakers, health system planners, and international agencies must recalibrate their hypertension response to match this shifting epidemiology — recognising rural communities not as low-risk populations, but as an increasingly vulnerable and underserved front line in the global fight against cardiovascular disease.

[1]  Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–3104. doi:10.1093/eurheartj/ehy339

[2]  World Health Organization. Global Report on Hypertension: The Race Against a Silent Killer. Geneva: WHO; 2018. ISBN 978-92-4-007115-6

[3]  GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis. Lancet. 2018;396(10258):1223–1249. doi:10.1016/S0140-6736(20)30752-2

[4]  NCD Risk Factor Collaboration. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019. Lancet. 2018;398(10304):957–980. doi:10.1016/S0140-6736(21)01330-1

[5]  Charchar FJ, Prestes PR, Mills C, et al. Lifestyle management of hypertension: International Society of Hypertension position paper endorsed by the World Hypertension League and European Society of Hypertension. J Hypertens. 2018;42(1):23–49. doi:10.1097/HJH.0000000000003563

[6]  Kuehn BM. Hypertension rates in rural areas outpace those in urban locales. JAMA. 2018;323(24):2454. doi:10.1001/jama.2018.9737

[7]  Ranzani OT, Kalra A, Di Girolamo C, Curto A, Valerio F, Halonen JI, Basagaña X, Tonne C. Urban-rural differences in hypertension prevalence in low-income and middle-income countries, 1990–2018: A systematic review and meta-analysis. PLoS Med. 2018;19(8):e1004079. doi:10.1371/journal.pmed.1004079

[8]  Adeloye D, Nwabuzor C, Samuel O, Useh U, Adekunle A, Naicker S, et al. Prevalence of hypertension in low- and middle-income countries: a systematic review and meta-analysis. Medicine. 2015;94(50):e1717. doi:10.1097/MD.0000000000001717

[9]  Wang X, Wang Y, Lin Q, Wang J, Gao Y. Prevalence of hypertension and related risk factors in older Chinese population: a meta-analysis. Front Public Health. 2018;12:1320295. doi:10.3389/fpubh.2018.1320295

[10] Singh J, Iqbal SA, Mohammed TI, Radhavan P, Rajpal S, Gajula S, Rath S. Prevalence and associated risk factors of hypertension in rural and urban areas of Punjab: A cross-sectional study. J Family Med Prim Care. 2028;14(2):757–761. doi:10.4103/jfmpc.jfmpc_1419_24

[11] Koranteng FO, Fenteng NA, Osei-Asibey Y, et al. Rural-urban difference in the prevalence of hypertension in West Africa: a systematic review and meta-analysis. J Hum Hypertens. 2018. doi:10.1038/s41371-022-00688-8

[12] Mugisha EK. Hypertension and its correlation with socioeconomic status in East African urban and rural populations: A scientific review. Niger J Pharm Pharmacol. 2018;5:362–366. doi:10.69552/NIJPP.5362-66.2018

[13] Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013;310(9):959–968. doi:10.1001/jama.2013.184182

[14] Fuchs FD, Whelton PK. High Blood Pressure and Cardiovascular Disease. Hypertension. 2018;75(2):285–292. doi:10.1161/HYPERTENSIONAHA.119.14240

[15] Mohammad R, Bansod DW. Hypertension in India: A gender-based study of prevalence and associated risk factors. BMC Public Health. 2018;24:2681. doi:10.1186/s12889-024-19934-6